相关实验视频
Updated: Jul 9, 2026
06:37
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
Published on: February 3, 2017
8.7K
酸盐预先调节的人类脂肪衍生的干细胞调节介质增强心肌梗塞后的心肌 perfusion
Shinji Kobuchi1, Wan-Tseng Hsu2, Misaki Matsuzawa3
1Laboratory of Pharmacokinetics, Kyoto Pharmaceutical University, Kyoto, Japan.
Regenerative therapy
|December 4, 2025
概括
丁酸盐预制增强脂肪衍生干细胞条件介质 (ASC-CM) 进行心脏修复. 这改善了细胞疗法,通过增强膜因子,导致更好的血管形成和小鼠的心脏功能.
科学领域:
- 再生医学是一种再生医学.
- 干细胞生物学 干细胞生物学
- 心血管研究研究心血管研究
背景情况:
- 脂肪衍生干细胞条件介质 (ASC-CM) 显示了通过对神经信号传递进行心脏修复的潜力.
- ASC-CM的临床翻译受到可变疗效的限制.
研究的目的:
- 调查人类ASCs的丁酸盐预条件是否会增强ASC-CM的副质功效.
- 评估丁酸盐预调剂对体外和体外心脏修复结果的影响.
主要方法:
- 用RNA测序来分析酸盐预先条件的ASC中的转录组变化.
- 对CM的细胞因子/化学因子阵列分析.
- 在实验室内皮内皮伤口愈合测试中使用HUVEC和THP-1巨细胞.
- 在体内血管新生评估使用海绵模型.
- 在老鼠心肌梗塞模型中通过SPECT/CT测量心肌 perfusion.
主要成果:
- 丁酸盐预先调节了血管新生和与免疫相关的基因 (例如CXCL8,SOD2,TGM2) 的升级,并增加了IL-10,CXCL5和MMP-1的分泌.
- 在实验室中,ASC-BA-CM增强了HUVEC的伤口关闭,在巨共同培养中改善了结果.
- 在体内,ASC-BA-CM促进了血管化和巨细胞的积累,显著改善了心肌 perfusion ~32%.
结论:
- 丁酸盐预制增强了ASC-CM的近活动.
- 这种增强与大鼠模型中心肌输液的改善有关,这表明ASC增强了分泌体功能.
- 需要进一步的研究来验证诸如内皮修复,血管新生和免疫调节等机制.
相关概念视频
01:20Exercise and Cardiovascular Response
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...